TLDR The document did not provide specific information on Telogen Effluvium.
The document, "Telogen Effluvium," is a part of the second edition of "Pediatric Dermatology: A Quick Reference Guide," which was a comprehensive guide for diagnosing, treating, and managing over 100 skin conditions in children and adolescents. The document provided practical, concise, and abundantly illustrated guidance for dealing with various dermatologic problems from birth through adolescence. However, the document did not provide specific information on the subject of Telogen Effluvium or any other specific skin conditions, making it impossible to summarize any conclusions or supporting facts related to hair loss, alopecia, or hair growth.
27 citations,
September 2012 in “Dermatologic Clinics” The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.
21 citations,
May 1996 in “Current problems in dermatology” Detailed patient history and physical exams are crucial for diagnosing hair loss.
2 citations,
December 2004 in “Medicine” Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.
218 citations,
January 2013 in “The Lancet Oncology” Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.
40 citations,
July 2017 in “Frontiers in Medicine” Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.
Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.
